Sleep spindles in early course schizophrenia and first-degree relatives
Sleep spindles in early course schizophrenia and first-degree relatives
批准号:
9702857
负责人:
MATCHERI S. KESHAVAN
金额:
$55.46万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-07 至 2022-05-31
关键词:
AdolescenceAgeAntipsychotic AgentsAreaBiological MarkersChronicCognitionCognitive deficitsCognitive remediationContralateralDevelopmentEarly InterventionEszopicloneFamilyFirst Degree RelativeFunctional disorderGeneral HospitalsHospitalsImpaired cognitionImpairmentIndividualIsraelLaboratoriesLearningLinkLiteratureMassachusettsMeasuresMediatingMedical centerModelingMotorNeurobiologyParticipantPatientsPilot ProjectsPopulationPredispositionPreventionPsychopathologyPsychotic DisordersRecording of previous eventsRelative RisksResistanceRiskSamplingSchizophreniaSleepSleep DeprivationSleep disturbancesSocioeconomic StatusStructureSymptomsTask PerformancesTimeWorkbasecognitive functiondensityeffective therapyemerging adultendophenotypeexecutive functionexperiencefunctional disabilityfunctional outcomeshigh riskimprovedmemory consolidationmental health centerneural correlateneuroimagingnon rapid eye movementnovelpublic health relevancerecruitrelating to nervous systemsexsleep abnormalitiessleep spindletrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A burgeoning literature suggests that sleep spindles mediate sleep-dependent memory consolidation and cognitive function more generally. At the same time, several recent studies show that sleep spindles are dramatically reduced in SZ. Cognitive deficits are a core feature of schizophrenia (SZ) that underlie significant functional disability and effective treatments are lacking. Previous work from our laboratories links the sleep spindle deficit with an impairment of sleep-dependent memory consolidation, IQ and executive function in SZ, and suggests that it is treatable. But it is unclear whether this sleep spindle deficit is present early in SZ, and whether it reflects a core disturbance central to its pathophysiology and familial risk of illness. In this study, we will examine sleep spindles, their relationship to memory consolidation and cognition more generally, and their neural underpinnings in early-course patients both with SZ (E-SZ; n=30), and with other psychoses (E-NSZ; n=30), in young relatives of SZ patients at familial high risk for SZ (FHR; n=60) and in healthy comparison (HC) subjects matched for age, sex and parental socioeconomic status. We hypothesize (i) that E-SZ and FHR, but not E-NSZ, will show reduced spindles compared with HC; (ii) that spindle number and density will correlate with sleep-dependent memory consolidation, IQ and overall cognitive function in all groups, and that deficient sleep spindles will correlate with positive and prodromal symptoms in E-SZ and FHR; and (iii) that during the sleep that follows motor task learning, HC and E-NSZ, but not E-SZ or FHR participants, will show increased spindle density and coherence, specifically in the motor network. We also predict that reduced spindle density will correlate with a reduction in thalamocortical functional and structural connectivity. Our hypotheses, if confirmed, will help establish the sleep spindle deficit as (i) an endophenotype of SZ, which can serve as a biomarker of familial risk (for studying the etiopathology of SZ), and (ii) a target for novel treatments of cognitive impairment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
-
批准号:10683233
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2022
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10396433
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10613507
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Longitudinal trajectories in treated and untreated schizophrenia
-
批准号:10306962
-
项目类别:
-
资助金额:$64.17万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Characterizing cognition across the lifespan in untreated psychosis in China
-
批准号:9403816
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9139499
-
项目类别:
-
资助金额:$62.48万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk
-
批准号:8976169
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2014
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8506547
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8706965
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8453355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8644914
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8236770
-
项目类别:
-
资助金额:$67.46万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8831006
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
CORE--CLINICAL
-
批准号:7553455
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes
-
批准号:9293368
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7668419
-
项目类别:
-
资助金额:$80.15万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7917305
-
项目类别:
-
资助金额:$77.04万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7384973
-
项目类别:
-
资助金额:$80.95万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
EFFECT OF QUETIAPINE ON DELTA SLEEP DEFICITS IN SCHIZOPHRENIA
-
批准号:7201198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
BRAIN CIRCUITRY AND COGNITION IN PSYCHOSIS
-
批准号:7201211
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: